QA: ENZO BIOCHEM INC in us_health_services/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2021_ENZO_BIOCHEM_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO BIOCHEM INC

  xvar xval
0 IntangibleAssets 7,990,000
1 AssetsNonCurrent 21,301,000
2 AssetsCurrent 68,765,000
3 PropertyPlantAndEquipment 14,482,000
4 remainder_Assets 0
5 LongTermLiabilities 21,356,000
6 LiabilitiesCurrent 32,801,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 52,251,000
10 GeneralAndAdministrativeExpense 42,960,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 4,448,000
16 remainder_Expenses 6,729,000
17 remainder_Revenues 76,021,000
18 remainder_NetIncome 1,847,000
19 remainder_ComprehensiveNetIncome -899,000
  yvar yval
0 Assets 112,538,000
1 Liabilities 54,157,000
2 Expenses 106,388,000
3 Revenues 76,021,000
4 StockholdersEquity 58,381,000
5 NetIncome -28,520,000
6 ComprehensiveNetIncome -29,419,000
7 BaseVar 206,475,575
8 EconomicCapitalRatio 0.714

Edgar->Model Mapping

Feature Distribution

Change over Time